Technology | October 17, 2007

EZ-EM to Spotlight Injectors, VoLumen Oral Contrast

EmpowerCTA injector offers both E-Z-EM’s patented extravasation detection accessory (EDA) and a saline chase. Modular CT injector features air embolism protection, on-the-fly flow rate manipulation, easy syringe loading and arming at the injector. IRiS software tracks: patient ID, creatinine values, GFR, consumable utilization, total contrast filled/injected/wasted, type of contrast, EDA activation status and number of EDA-identified extravasations.

Also featured, the E-Z-EM EmpowerMR injector reportedly provides virtually no injector RF in the scanner room, consistent flow rate delivery, pressure performance on demand, improved productivity and compatibility up to 7T environments.
EmpowerMR employs a hydraulic control system instead of the shielded electrical control components used by most other MR injector systems. EmpowerMR has no shielded iron motors, piezoelectric motors and electrically active motor control circuitry adjacent to the scanner, which significantly minimizes the prospect of electrical interference with the scanner's magnetic field. EmpowerMR is also not battery operated, and links to its electrical supply by a single pass-through cable that does not require special shielding.

E-Z-EM’s VoLumen is a low Hounsfield value oral contrast for MDCT and PET/CT studies designed to overcome the limitations of water and other higher-density positive oral contrasts. It reportedly allows for the simultaneous investigation of all organs, vasculature and surrounding structures of the abdominal/pelvic region and is used in CT Enterography (CTE) for the diagnosis/evaluation of Crohn's disease and other inflammatory bowel disease. It also reportedly minimizes X-ray attenuation, reducing isotope uptake artifacts in PET/CT. VoLumen does not convert to glucose, so it does not interfere with the injection of the glucose-based radioactive contrasts.

Related Content

Study Finds No Evidence that Gadolinium Causes Neurologic Harm

MR images through, A, C, E, basal ganglia and, B, D, F, posterior fossa at level of dentate nucleus. Images are shown for, A, B, control group patient 4, and the, C, D, first and, E, F, last examinations performed in contrast group patient 13. Regions of interest used in quantification of signal intensity are shown as dashed lines for globus pallidus (green), thalamus (blue), dentate nucleus (yellow), and pons (red).

News | Contrast Media | January 11, 2018
January 11, 2018 — There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive dec
Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Imaging | January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
Videos | Magnetic Resonance Imaging (MRI) | December 19, 2017
Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pitt
The FDA issued new warnings on MRI gadolinium contrast agents. (GBCAs)

The FDA issued new warnings on MRI gadolinium contrast agents. 

Feature | Magnetic Resonance Imaging (MRI) | December 19, 2017
The U.S.
Brainlab Contrast Clearance Analysis Software Receives FDA 510(k) Clearance
Technology | Contrast Media | December 12, 2017
Brainlab announced U.S. Food and Drug Administration (FDA) clearance of its Contrast Clearance Analysis methodology,...
Sectra Offers Gadolinium Tracking Functionality in DoseTrack Software
Technology | Contrast Media | December 11, 2017
December 11, 2017 — Sectra recently announced the global introduction of gadolinium tracking in its dose monitoring s
Videos | Magnetic Resonance Imaging (MRI) | December 07, 2017
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MR
Guerbet to Participate in French Interventional Radiology Conference
News | Contrast Media | October 10, 2017
Guerbet announced it will be taking part in the 65th edition of the Journées Francophones de Radiologie (JFR) that will...
Trends in contrast media used in magnetic resonance imaging and computed tomography

Image courtesy of Bayer

Feature | Contrast Media | October 04, 2017 | By Dave Fornell
Over the past decade, several clinical studies have shown gadolinium-based magnetic resonance imaging (MRI) contrast...
Overlay Init